# Molecular and Cellular Mechanisms of Static and Repetitive Magnetic Stimulation in Cancer Therapy: A Scoping Review

**Authors:** Dirson Stein, Amanda Stieven, Rodrigo Hernandes Paludo, Khetrüin Jordana Fiuza, Lucas Rosa Fraga, Felipe Fregni, Wolnei Caumo, Mariane da Cunha Jaeger, Iraci L. S. Torres

PMC · DOI: 10.3390/biomedicines14030638 · Biomedicines · 2026-03-12

## TL;DR

This review explores how static and repetitive magnetic stimulation may affect cancer cells and their potential as non-invasive cancer therapies.

## Contribution

The study systematically reviews the molecular and cellular effects of static and repetitive magnetic stimulation in cancer models.

## Key findings

- Both rMS and sMS produce varied biological responses in cancer cells.
- Responses depend on tumor type, stimulation frequency, and experimental conditions.
- Nine rMS and sixteen sMS studies were analyzed across in vitro and in vivo models.

## Abstract

Repetitive magnetic stimulation (rMS) and static magnetic stimulation (sMS) are currently employed as adjunctive therapies for specific neurological conditions. Despite substantial advances in cancer treatment, unfavorable prognoses and outcomes persist, especially for aggressive tumors, including glioblastoma and acute myeloid leukemia. The utilization of magnetic fields has shown antitumoral benefits in both in vitro and animal studies, suggesting its potential as an efficient non-invasive therapeutic approach; nevertheless, the precise mechanisms of action remain unclear. This scoping review intended to identify published research investigating the effects of sMS and rMS in in vitro and in vivo models to evaluate their impacts on morphological and molecular parameters. Four databases (PubMed, Embase, Web of Science, and Scopus) were assessed; the search strategy was limited to the past twenty-five years of data publication. Studies utilizing rMS or sMS as a treatment for conditions other than cancers, as well as those not considering these therapies as adjunctive therapy, were eliminated. Nine articles using rMS were included: three in vitro, two employing animal models, and the remaining four including both cellular and animal-based analyses. Sixteen studies using sMS were identified: twelve in vitro, three in vivo, and one with both models. The findings show that both rMS and sMS elicit a diverse array of biological responses in cancer cells, which are very variable and greatly influenced by tumor type, stimulation frequency, magnetic field intensity, exposure length, and experimental conditions.

## Linked entities

- **Diseases:** glioblastoma (MONDO:0018177), acute myeloid leukemia (MONDO:0015667)

## Full-text entities

- **Diseases:** glioblastoma (MESH:D005909), Cancer (MESH:D009369), neurological conditions (MESH:D019636), acute myeloid leukemia (MESH:D015470)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13024157/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13024157/full.md

## References

69 references — full list in the complete paper: https://tomesphere.com/paper/PMC13024157/full.md

---
Source: https://tomesphere.com/paper/PMC13024157